» Articles » PMID: 20448280

Current Evidence for a Strategic Approach to the Management of Rheumatoid Arthritis with Disease-modifying Antirheumatic Drugs: a Systematic Literature Review Informing the EULAR Recommendations for the Management of Rheumatoid Arthritis

Overview
Journal Ann Rheum Dis
Specialty Rheumatology
Date 2010 May 8
PMID 20448280
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To perform a systematic literature review of effective strategies for the treatment of rheumatoid arthritis (RA).

Methods: As part of a European League Against Rheumatism (EULAR) Task Force investigation, a literature search was carried out from January 1962 until February 2009 in PubMed/Ovid Embase/Cochrane and EULAR/American College of Rheumatism (ACR)) abstracts (2007/2008) for studies with a treatment strategy adjusted to target a predefined outcome. Articles were systematically reviewed and clinical outcome, physical function and structural damage were compared between intensive and less intensive strategies. The results were evaluated by an expert panel to consolidate evidence on treatment strategies in RA.

Results: The search identified two different kinds of treatment strategies: strategies in which the reason for treatment adjustment differed between the study arms ('steering strategies', n=13) and strategies in which all trial arms used the same clinical outcome to adjust treatment with different pharmacological treatments ('medication strategies', n=7). Both intensive steering strategies and intensive medication strategies resulted in better outcome than less intensive strategies in patients with early active RA.

Conclusion: Intensive steering strategies and intensive medication strategies produce a better clinical outcome, improved physical function and less structural damage than conventional steering or treatment. Proof in favour of any steering method is lacking and the best medication sequence is still not known.

Citing Articles

Prevalence of wound infections and postoperative complications after total elbow arthroplasty for rheumatoid arthritis: A meta-analysis.

Chen Q, Liu L, Gu F Int Wound J. 2023; .

PMID: 37867410 PMC: 10828120. DOI: 10.1111/iwj.14451.


Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies.

Genovese M, Durez P, Fleischmann R, Tanaka Y, Furst D, Yamanaka H Eur J Rheumatol. 2021; 8(3):120-129.

PMID: 34101570 PMC: 9770405. DOI: 10.5152/eurjrheum.2021.19207.


[Tight control-Demand for short term control of rheumatoid arthritis].

Schneider M, Burmester G Z Rheumatol. 2019; 78(5):404-412.

PMID: 31001653 DOI: 10.1007/s00393-019-0631-x.


Intensive therapy and remissions in rheumatoid arthritis: a systematic review.

Hughes C, Scott D, Ibrahim F BMC Musculoskelet Disord. 2018; 19(1):389.

PMID: 30376836 PMC: 6208111. DOI: 10.1186/s12891-018-2302-5.


Factors influencing the use of biologic therapy and adoption of treat-to-target recommendations in current European rheumatology practice.

Taylor P, Alten R, Gomez Reino J, Caporali R, Bertin P, Sullivan E Patient Prefer Adherence. 2018; 12:2007-2014.

PMID: 30323570 PMC: 6179241. DOI: 10.2147/PPA.S170054.